Eur J Immunol. 2007 Dec;37(12):3582-6.

Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.

Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL.

Source

Dynavax Technologies Corporation, Berkeley, CA 94710, USA. fbarrat@dynavax.com

Abstract

The presence of autoantibodies specific for nucleic acid-associated antigens is the hallmark of systemic lupus erythematosus (SLE). We have recently developed a specific inhibitor of TLR7 and TLR9, called immunoregulatory sequence (IRS) 954, and showed that it inhibits the induction of IFN-alpha by human plasmacytoid dendritic cells in response to DNA and RNA viruses and isolated immune complexes from lupus patients. In this study, we show that IRS 954 can prevent progression of disease when injected in the lupus prone (NZBxNZW)F1 mice. Following treatment, we observed a significant reduction of serum levels of nucleic acid-specific autoantibodies as well as decreased proteinuria, reduced glomerulonephritis, end-organ damage and increased survival. These data demonstrate that in addition to its ability to block IFN-alpha, IRS 954 can reduce symptoms in a lupus model and thus represents a promising therapeutic agent for the treatment of SLE.

PMID:: 18034431; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Lupus - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. [J Autoimmun. 2010]
Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S, Reith W, Mohan C, Kotzin BL, Izui S. J Autoimmun. 2010 Jun; 34(4):339-48. Epub 2009 Nov 26.
DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo. [Arthritis Res Ther. 2009]
DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P, Yasuda K, Busconi L, Nelson P, Fleenor C, Ratnabalasuriar RS, Nagy PL, Ashman RF, Rifkin IR, Marshak-Rothstein A. Arthritis Res Ther. 2009; 11(3):R79. Epub 2009 May 28.
Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. [Arthritis Res Ther. 2009]
Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL, Graham KL, Lee LY, Balboni I, Hertzog PJ, Utz PJ. Arthritis Res Ther. 2009; 11(4):R112. Epub 2009 Jul 22.
Review Emerging roles of TLR7 and TLR9 in murine SLE. [J Autoimmun. 2009]
Review Emerging roles of TLR7 and TLR9 in murine SLE.
Santiago-Raber ML, Baudino L, Izui S. J Autoimmun. 2009 Nov-Dec; 33(3-4):231-8. Epub 2009 Oct 21.
Review Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor. [Autoimmunity. 2003]
Review Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.
Kono DH, Baccala R, Theofilopoulos AN. Autoimmunity. 2003 Dec; 36(8):503-10.

See reviews... See all...

Cited by 38 PubMed Central articles

Review Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes. [J Biomed Biotechnol. 2011]
Review Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.
Karageorgas TP, Tseronis DD, Mavragani CP. J Biomed Biotechnol. 2011; 2011:273907. Epub 2011 Nov 16.
Review Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease. [Parasit Vectors. 2011]
Review Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease.
Sun S, Wang X, Wu X, Zhao Y, Wang F, Liu X, Song Y, Wu Z, Liu M. Parasit Vectors. 2011 Sep 27; 4:186. Epub 2011 Sep 27.
Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. [PLoS One. 2011]
Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis.
Tadema H, Abdulahad WH, Stegeman CA, Kallenberg CG, Heeringa P. PLoS One. 2011; 6(9):e24315. Epub 2011 Sep 6.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to re...
Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.
Eur J Immunol. 2007 Dec ;37(12):3582-6.

PubMed
Barriers and missed opportunities to HIV testing among injection drug users in t...
Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities.
Drug Alcohol Rev. 2008 Jan ;27(1):39-45.

PubMed
Dentoalveolar open bite treatment with spur appliances.
Dentoalveolar open bite treatment with spur appliances.
J Orofac Orthop. 2007 Nov ;68(6):510-21.

PubMed
In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemo...
In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent.
Lung. 2008 Jan-Feb ;186(1):45-54. Epub 2007 Nov 22 .

PubMed
The Cataract National Dataset electronic multi-centre audit of 55,567 operations...
The Cataract National Dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally.
Eye (Lond). 2009 Jan ;23(1):38-49. Epub 2007 Nov 23 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: